The costs for 806 patients with overweight or obesity and heart failure were analyzed in one study. For those patients, the average total medical costs dropped from $29,654 before treatment began to ...

Pennington Biomedical Research Center researchers at the Metamor Institute, along with colleagues from Our Lady of the Lake and LSU Health-New Orleans, have recently determined that metabolic surgery ...

Risk for heart failure events is decreased and health status is improved in patients with HFmrEF and HFpEF receiving finerenone.

Background: Standard pharmacotherapy for patients with heart failure with reduced ejection fraction (HFrEF) comprises “quadruple therapy” with a renin–angiotensin system inhibitor, a β-blocker, a ...

Menopause: it’s a natural part of aging that affects millions of people each year, and yet there’s still plenty that we don’t know about it. It’s widely considered to be understudied and ...

People with type 2 diabetes are at a high risk of developing severe health complications such as heart attacks, strokes, heart failure ... and kidney health. The drug, known as sodium-glucose ...

Heart failure (HF) is a leading cause of morbidity and mortality worldwide. Testing for natriuretic peptide markers, such as B-type natriuretic peptide (BNP) or N-terminal proBNP (NT-proBNP), has ...

Three other people were critically injured, officials said. The "catastrophic failure" of an aluminum ferry gangway caused the deaths Saturday of seven people who were attending an annual cultural ...

Weight-loss drugs are already at the heart of the national debate. This week, the new Labour government suggested they could be a tool to help obese people in England off benefits and back into work.

The Department of Justice announced Thursday that TD Bank will pay more than $3 billion in fines and penalties over its failure to monitor ... operations by drug cartels. "TD Bank created an ...

“Despite the huge socioeconomic burden of heart attack and heart failure, there is not a single drug to limit the loss of heart cells during an attack or to protect donor hearts – our team ...

Reuters: Novartis Loses Latest Bid To Block Generic Version Of Blockbuster Heart Drug Novartis has lost a bid to keep a generic version of its top-selling heart failure drug Entresto off the U.S.